InsidersTradesSigma
基于 4 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the detailed record of transactions filed by Rowland Thomas Andrew. Officer active across 1 company, notably ANI Pharmaceuticals INC. Aggregated, 8 reports have been logged. Split: 0 buy · 1 sell. Total volume traded: €365k. History available since 15 November 2024. The latest transaction was disclosed on 14 February 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Rowland Thomas Andrew is a declarant linked to ANI Pharmaceuticals INC, where he holds the role of SVP, HEAD - ESTABLISHED BRANDS. He has 7 filings in total, and the 7 sampled filings span 2024-11-18 to 2026-02-17, with transaction amounts tied to tax withholding and individual amounts up to EUR 46585.43870024199.